These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8394044

  • 1. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
    Fujiki H, Suganuma M.
    Adv Cancer Res; 1993; 61():143-94. PubMed ID: 8394044
    [No Abstract] [Full Text] [Related]

  • 2. [Tumor promotion by inhibitors of protein phosphatase 1 and 2A].
    Suganuma M, Fujiki H.
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1102-10. PubMed ID: 9655968
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A.
    MacKintosh C, Klumpp S.
    FEBS Lett; 1990 Dec 17; 277(1-2):137-40. PubMed ID: 2176611
    [Abstract] [Full Text] [Related]

  • 6. [Naturally occurring toxins with specific inhibitory activity against protein serine/threonine phosphatases 1 and 2A].
    Takai A.
    Tanpakushitsu Kakusan Koso; 1998 Jun 17; 43(8 Suppl):1091-101. PubMed ID: 9655967
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitors of protein phosphatases (okadaic acid and tautomycin) block sea urchin development.
    Troll W, Sueoka N, Sueoka E, Laskin JD, Heck DE.
    Biol Bull; 1995 Jun 17; 189(2):201. PubMed ID: 8541399
    [No Abstract] [Full Text] [Related]

  • 8. Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.
    Suganuma M, Okabe S, Sueoka E, Nishiwaki R, Komori A, Uda N, Isono K, Fujiki H.
    J Cancer Res Clin Oncol; 1995 Jun 17; 121(9-10):621-7. PubMed ID: 7559747
    [Abstract] [Full Text] [Related]

  • 9. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
    McCluskey A, Sim AT, Sakoff JA.
    J Med Chem; 2002 Mar 14; 45(6):1151-75. PubMed ID: 11881984
    [No Abstract] [Full Text] [Related]

  • 10. A new pathway of tumor promotion by the okadaic acid class compounds.
    Fujiki H, Suganuma M, Nishiwaki S, Yoshizawa S, Winyar B, Sugimura T, Schmitz FJ.
    Adv Second Messenger Phosphoprotein Res; 1990 Mar 14; 24():340-4. PubMed ID: 2169814
    [No Abstract] [Full Text] [Related]

  • 11. Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts.
    Ariza RR, Keyse SM, Moggs JG, Wood RD.
    Nucleic Acids Res; 1996 Feb 01; 24(3):433-40. PubMed ID: 8602355
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
    Fujiki H, Suganuma M, Yoshizawa S, Nishiwaki S, Winyar B, Sugimura T.
    Environ Health Perspect; 1991 Jun 01; 93():211-4. PubMed ID: 1663450
    [Abstract] [Full Text] [Related]

  • 13. A pharmacophore model of tautomycin, an inhibitor of protein phosphatases 1 and 2A.
    Ubukata M, Koshino H, Yamasaki C, Fujita K, Isono K.
    J Antibiot (Tokyo); 1997 Oct 01; 50(10):801-7. PubMed ID: 9402983
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of protein phosphatases-1 and -2A with acanthifolicin. Comparison with diarrhetic shellfish toxins and identification of a region on okadaic acid important for phosphatase inhibition.
    Holmes CF, Luu HA, Carrier F, Schmitz FJ.
    FEBS Lett; 1990 Sep 17; 270(1-2):216-8. PubMed ID: 2171991
    [Abstract] [Full Text] [Related]

  • 15. Identification of a 42 kDa protein as a substrate of protein phosphatase 1 in cilia from Paramecium.
    Klumpp S, Schultz JE.
    FEBS Lett; 1991 Aug 19; 288(1-2):60-4. PubMed ID: 1652480
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity.
    Yoshizawa S, Matsushima R, Watanabe MF, Harada K, Ichihara A, Carmichael WW, Fujiki H.
    J Cancer Res Clin Oncol; 1990 Aug 19; 116(6):609-14. PubMed ID: 2174896
    [Abstract] [Full Text] [Related]

  • 17. Role of phosphoprotein phosphatases in the corpus luteum: I identification and characterisation of serine/threonine phosphoprotein phosphatases in isolated rat luteal cells.
    Ford SL, Abayasekara DR, Persaud SJ, Jones PM.
    J Endocrinol; 1996 Aug 19; 150(2):205-11. PubMed ID: 8869587
    [Abstract] [Full Text] [Related]

  • 18. A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
    Gupta V, Ogawa AK, Du X, Houk KN, Armstrong RW.
    J Med Chem; 1997 Sep 26; 40(20):3199-206. PubMed ID: 9379439
    [Abstract] [Full Text] [Related]

  • 19. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle.
    Gong MC, Cohen P, Kitazawa T, Ikebe M, Masuo M, Somlyo AP, Somlyo AV.
    J Biol Chem; 1992 Jul 25; 267(21):14662-8. PubMed ID: 1321813
    [Abstract] [Full Text] [Related]

  • 20. Neuronal differentiation of Neuro 2a cells by lactacystin and its partial inhibition by the protein phosphatase inhibitors calyculin A and okadaic acid.
    Tanaka H, Katagiri M, Arima S, Matsuzaki K, Inokoshi J, Omura S.
    Biochem Biophys Res Commun; 1995 Nov 02; 216(1):291-7. PubMed ID: 7488103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.